Effect of calcium entry and beta blockade during infrarenal aortic clamping

S G Lalka1, R S Rhodes, A A Lina

  • 1Department of Surgery, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106.

Insights

Verapamil and propranolol combination therapy adversely affects cardiovascular response during aortic surgery. This combination therapy showed more negative effects than either drug alone, requiring caution in patients undergoing abdominal aortic procedures.

Area of Science:

  • Cardiovascular Physiology
  • Anesthesiology
  • Pharmacology

Background:

  • Aortic surgery involves myocardial stress from clamping and declamping.
  • Cardiovascular drugs like calcium antagonists and beta-blockers may alter the response to this stress.
  • Symptomatic coronary artery disease often necessitates these medications.

Purpose of the Study:

  • To evaluate the combined and individual effects of verapamil and propranolol on cardiovascular response during aortic cross-clamping and declamping.
  • To compare the effects of verapamil (V), propranolol (P), and their combination (P + V) against a control group in anesthetized dogs.

Main Methods:

  • Anesthetized dogs were divided into four groups: control, propranolol (P), verapamil (V), and combination (P + V).
  • Drugs were administered prior to and during aortic cross-clamping and declamping procedures.
  • Hemodynamic parameters including heart rate, blood pressure, cardiac output, and ventricular pressures were measured.

Main Results:

  • The combination of verapamil and propranolol (P + V) exhibited additive negative chronotropic and inotropic effects.
  • The P + V therapy resulted in a more significantly adverse cardiovascular response compared to either drug administered alone.
  • Individual administration of verapamil or propranolol also altered cardiovascular parameters, but to a lesser extent than the combination.

Conclusions:

  • Combined verapamil and propranolol therapy poses a greater risk during abdominal aortic surgery due to amplified negative cardiovascular effects.
  • Clinicians should exercise increased caution when patients on these medications undergo abdominal aortic surgery.
  • Further research may be warranted to explore alternative anesthetic or pharmacologic strategies for such patients.

Related Concept Videos

Feedback Regulation of Calcium Concentration01:27

Feedback Regulation of Calcium Concentration

Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...